MRC1 and intestinal cancer: Moreover, non-tumorous mucosa from resections for intestinal cancer revealed a frequent occurrence of MMR-deficient crypt foci in LS mutation carriers, which contrasts with the low number of adenomas and carcinomas becoming clinically manifested and underlines the necessity of other tumorigenic events before or after MMR gene inactivation [27].